title: Electrophysiological properties and chemosensitivity of acutely dissociated trigeminal somata innervating the cornea.
abstract: Adult rat sensory trigeminal ganglion neurons innervating the cornea (cTGNs) were isolated and identified following retrograde dye labeling with FM1-43. Using standard whole-cell patch clamp recording techniques, cTGNs could be subdivided by their action potential (AP) duration. Fast cTGNs had AP durations <1 ms (40%) while slow cTGNs had AP durations >1 ms and an inflection on the repolarization phase of the AP. With the exception of membrane input resistance, the passive membrane properties of fast cTGNs were different from those of slow cTGNs (capacitance: 61+/-4.5 pF vs. 42+/-2.6 pF, resting membrane potential: -59+/-0.7 mV vs. -53+/-0.9 mV, for fast and slow cTGNs respectively). Active membrane properties also differed between fast and slow cTGNs. Slow cTGNs had a higher AP threshold (-25+/-1.6 mV vs. -38+/-0.8 mV), a larger rheobase (14+/-1.9 pA/pF vs. 6.8+/-1.0 pA/pF), and a smaller AP undershoot (-56+/-1.7 mV vs. -67+/-2.5 mV). The AP overshoot, however was similar between the two types of neurons (46+/-3.1 mV vs. 48+/-4 mV). Slow cTGNs were depolarized by capsaicin (1 microM, 80%) and 60% of their APs were blocked by tetrodotoxin (TTX) (100 nM). Fast cTGNs were unaffected by capsaicin and 100% of their APs were blocked by TTX. Similarly, cTGNs were also heterogeneous with respect to their responses to exogenous ATP and 5-HT. The current work shows that cTGNs have distinctive electrophysiological properties and chemosensitivity profiles. These characteristics may mirror the distinct properties of corneal sensory nerve terminals. The availability of isolated identified cTGNs constitutes a tractable model system to investigate the biophysical and pharmacological properties of corneal sensory nerve terminals.
authors: Department of Pharmacology and Experimental Therapeutics, University of Maryland, School of Medicine, 655 West Baltimore Street, Baltimore, MD 21201, USA.
authors: T H
authors: TH
authors: Veiga Moreira
authors: T D
authors: TD
authors: Gover
authors: D
authors: D
authors: Weinreich
mesh_terms: D000200:Action Potentials / Q000187:drug effects / Q000502:physiology*; D000818:Animals; D002211:Capsaicin / Q000494:pharmacology; D002478:Cells, Cultured; D003315:Cornea / Q000294:innervation* / Q000502:physiology; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology; D009475:Neurons, Afferent / Q000187:drug effects / Q000502:physiology*; D009619:Nociceptors / Q000187:drug effects / Q000502:physiology*; D009882:Ophthalmic Nerve / Q000187:drug effects / Q000502:physiology*; D010146:Pain / Q000503:physiopathology; D018408:Patch-Clamp Techniques; D017729:Presynaptic Terminals / Q000187:drug effects / Q000502:physiology; D011726:Pyridinium Compounds; D000644:Quaternary Ammonium Compounds; D051381:Rats; D017207:Rats, Sprague-Dawley; D026941:Sodium Channel Blockers / Q000494:pharmacology; D012668:Trigeminal Ganglion / Q000187:drug effects / Q000502:physiology*
chemical_list: C073804:FM1 43; D011726:Pyridinium Compounds; D000644:Quaternary Ammonium Compounds; D026941:Sodium Channel Blockers; D002211:Capsaicin
references: J Physiol. 2005 Jun 15;565(Pt 3):927-43
references: 15831536
references: J Pharmacol Exp Ther. 2005 Jul;314(1):437-45
references: 15831438
references: Cell Calcium. 2007 Apr;41(4):389-96
references: 17046058
references: Brain Res Mol Brain Res. 1999 Dec 10;74(1-2):55-68
references: 10640676
references: Neuroscience. 2000;101(4):1109-15
references: 11113359
references: Annu Rev Physiol. 2001;63:871-94
references: 11181979
references: Prog Neurobiol. 2001 Oct;65(2):107-34
references: 11403876
references: Cephalalgia. 2002 Jul;22(6):424-31
references: 12133041
references: Exp Eye Res. 2003 May;76(5):521-42
references: 12697417
references: J Neurosci. 2003 May 15;23(10):4054-65
references: 12764092
references: Life Sci. 2003 Jul 18;73(9):1175-87
references: 12818725
references: J Neurosci. 2003 Jun 15;23(12):4793-7
references: 12832498
references: J Physiol. 2003 Aug 1;550(Pt 3):739-52
references: 12794175
references: J Neurosci. 2003 Nov 12;23(32):10338-50
references: 14614093
references: J Neurosci. 2003 Nov 26;23(34):10988-97
references: 14645495
references: Neurosci Lett. 1981 May 29;23(3):243-9
references: 6167911
references: Neurosci Lett. 1984 Nov 23;52(1-2):117-22
references: 6527829
references: Invest Ophthalmol Vis Sci. 1989 Mar;30(3):461-72
references: 2494126
references: J Neurosci Methods. 1990 Jun;32(3):213-22
references: 2385139
references: J Physiol. 1991 Jun;437:709-25
references: 1890657
references: J Comp Neurol. 1991 Nov 1;313(1):132-50
references: 1761750
references: Neuroscience. 1993 Jul;55(2):521-9
references: 7690911
references: J Neurosci. 1993 Oct;13(10):4511-24
references: 8410200
references: Br J Pharmacol. 1997 Feb;120(3):469-75
references: 9031751
references: J Neurophysiol. 1997 Dec;78(6):3198-209
references: 9405539
references: Cephalalgia. 1997 Dec;17(8):833-42
references: 9453271
references: J Appl Physiol (1985). 1998 Jul;85(1):123-8
references: 9655764
references: Eur J Neurosci. 1998 Nov;10(11):3470-8
references: 9824460
references: Annu Rev Neurosci. 1999;22:443-85
references: 10202545
references: Arch Histol Cytol. 1999 May;62(2):129-38
references: 10399537
references: Neuroscience. 1999;93(2):713-22
references: 10465455
references: Neurosci Lett. 2005 Aug 26;384(3):294-9
references: 15908117